hydrochlorothiazide has been researched along with Goldblatt Syndrome in 20 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrochlorothiazide was administered from 8 weeks, and LV mass and function were measured at 16 weeks after surgery to induce hypertension." | 5.29 | Hydrochlorothiazide improves ventricular compliance and thus performance without reducing hypertrophy in renal artery stenosis in rats. ( Norton, GR; Tsotetsi, OJ; Woodiwiss, AJ, 1993) |
| "Hydrochlorothiazide was administered from 8 weeks, and LV mass and function were measured at 16 weeks after surgery to induce hypertension." | 1.29 | Hydrochlorothiazide improves ventricular compliance and thus performance without reducing hypertrophy in renal artery stenosis in rats. ( Norton, GR; Tsotetsi, OJ; Woodiwiss, AJ, 1993) |
| "In spontaneously hypertensive rats (SHR), after 1 day of dosing with an angiotensin-converting enzyme (ACE) inhibitor (captopril or enalapril) plus a diuretic (hydrochlorothiazide), a synergistic antihypertensive effect was observed when a second dose of the combination or ACE inhibitor alone but not the diuretic alone was given the next day." | 1.27 | Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics. ( Cervoni, P; Chan, PS; Ronsberg, MA, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (75.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceron, CS | 1 |
| Castro, MM | 1 |
| Rizzi, E | 1 |
| Montenegro, MF | 1 |
| Fontana, V | 1 |
| Salgado, MC | 1 |
| Gerlach, RF | 1 |
| Tanus-Santos, JE | 1 |
| Piryova, B | 1 |
| Girchev, R | 1 |
| Chan, PS | 1 |
| Ronsberg, MA | 1 |
| Cervoni, P | 1 |
| Havelka, J | 1 |
| Vetter, H | 1 |
| Studer, A | 1 |
| Greminger, P | 1 |
| Lüscher, T | 1 |
| Wollnik, S | 1 |
| Siegenthaler, W | 1 |
| Vetter, W | 1 |
| Wenting, GJ | 1 |
| de Bruyn, JH | 1 |
| Man in't Veld, AJ | 1 |
| Woittiez, AJ | 1 |
| Derkx, FH | 1 |
| Schalekamp, MA | 1 |
| Ribeiro, AB | 1 |
| Alves Filho, G | 1 |
| de Almeida, FA | 1 |
| Kohlmann Junior, O | 1 |
| Stella, SR | 1 |
| Ramos, OL | 1 |
| Röckel, A | 1 |
| Heidland, A | 1 |
| Amery, A | 1 |
| Birkenhäger, W | 1 |
| Bogaert, M | 1 |
| Brixko, P | 1 |
| Bulpitt, C | 1 |
| Clement, D | 1 |
| De Leeuw, P | 1 |
| De Plaen, JF | 1 |
| Deruyttere, M | 1 |
| De Schaepdryver, A | 1 |
| Fagard, R | 1 |
| Forette, F | 1 |
| Forte, J | 1 |
| Hamdy, R | 1 |
| Hellemans, J | 1 |
| Henry, JF | 1 |
| Koistinen, A | 1 |
| Laaser, U | 1 |
| Laher, M | 1 |
| Leonetti, G | 1 |
| Lewis, P | 1 |
| Lund-Johansen, P | 1 |
| MacFarlane, J | 1 |
| Meurer, K | 1 |
| Miguel, P | 1 |
| Morris, J | 1 |
| Mutsers, A | 1 |
| Nissinen, A | 1 |
| O'Brien, E | 1 |
| Ohm, OJ | 1 |
| O'Malley, K | 1 |
| Pelemans, W | 1 |
| Perera, N | 1 |
| Tuomilehto, J | 1 |
| Verschueren, LJ | 1 |
| Willemse, P | 1 |
| Williams, B | 1 |
| Zanchetti, A | 1 |
| Norton, GR | 1 |
| Tsotetsi, OJ | 1 |
| Woodiwiss, AJ | 1 |
| Champ, JD | 1 |
| Wolf, G | 1 |
| Schneider, A | 1 |
| Wenzel, U | 1 |
| Helmchen, U | 1 |
| Stahl, RA | 1 |
| Lee, HB | 1 |
| Blaufox, MD | 1 |
| Dworkin, LD | 1 |
| Grosser, M | 1 |
| Feiner, HD | 1 |
| Ullian, M | 1 |
| Parker, M | 1 |
| Reams, GP | 1 |
| Bauer, JH | 1 |
| Franklin, SS | 2 |
| Smith, RD | 2 |
| Johnson, AL | 1 |
| Price, WA | 1 |
| Wong, PC | 1 |
| Vavala, RF | 1 |
| Stump, JM | 1 |
| Thind, GS | 1 |
| Herrera-Acosta, J | 1 |
| Gabbai, FB | 1 |
| Tapia, E | 1 |
| Cermeño, JL | 1 |
| Calleja, C | 1 |
| Bobadilla, NA | 1 |
| Romero, L | 1 |
| Cressman, M | 1 |
| Tarazi, RC | 1 |
4 trials available for hydrochlorothiazide and Goldblatt Syndrome
| Article | Year |
|---|---|
Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE).
Topics: Aged; Blood Glucose; Blood Pressure; Creatinine; Drug Therapy, Combination; Electrolytes; Female; Hu | 1982 |
Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Meth | 1985 |
Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
Topics: Adult; Aged; Blood Pressure; Enalapril; Female; Glomerular Filtration Rate; Humans; Hydralazine; Hyd | 1985 |
A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension.
Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; | 1986 |
16 other studies available for hydrochlorothiazide and Goldblatt Syndrome
| Article | Year |
|---|---|
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.
Topics: Animals; Antioxidants; Aorta; Blood Pressure; Drug Therapy, Combination; Hydrochlorothiazide; Hypert | 2010 |
Converting enzyme activity in regulation of blood pressure and kidney function. A review.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Drug T | 1984 |
Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aprotinin; Captopril; Dipeptides; Drug Synergism; | 1984 |
Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Creatinine; Dose-R | 1982 |
Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
Topics: Blood Pressure; Captopril; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; H | 1982 |
[Captopril in the clinical treatment of renovascular hypertension].
Topics: Adult; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hy | 1980 |
[Treatment of "therapy-resistant" forms of hypertension with captopril].
Topics: Ambulatory Care; Antihypertensive Agents; Captopril; Diuretics; Drug Resistance; Furosemide; Humans; | 1981 |
Hydrochlorothiazide improves ventricular compliance and thus performance without reducing hypertrophy in renal artery stenosis in rats.
Topics: Animals; Blood Pressure; Cardiomegaly; Compliance; Coronary Circulation; Dextrans; Heart; Heart Vent | 1993 |
Case report: azotemia secondary to enalapril and diuretic use and the diagnosis of renovascular hypertension.
Topics: Acute Kidney Injury; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension, Renovascular; Mid | 1993 |
Regulation of glomerular TGF-beta expression in the contralateral kidney of two-kidney, one-clip hypertensive rats.
Topics: Animals; Antihypertensive Agents; Drug Combinations; Hydralazine; Hydrochlorothiazide; Hypertension, | 1998 |
Renal functional response to captopril during diuretic therapy.
Topics: Animals; Captopril; Chlorothiazide; Furosemide; Hydrochlorothiazide; Hypertension, Renovascular; Iod | 1992 |
Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.
Topics: Animals; Antihypertensive Agents; Captopril; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertensi | 1989 |
Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl-(S)-pyroglutamic acid.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood | 1985 |
Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
Topics: Acute Kidney Injury; Captopril; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypert | 1985 |
Effect of captopril and hydrochlorothiazide on glomerular haemodynamics and histological damage in Goldblatt hypertension with partial renal ablation.
Topics: Animals; Captopril; Hemodynamics; Hydrochlorothiazide; Hypertension, Renovascular; Kidney Glomerulus | 1986 |
Therapeutic rounds.
Topics: Captopril; Drug Resistance; Female; Humans; Hydrochlorothiazide; Hypertension, Renovascular; Middle | 1985 |